Home/Filings/4/0001415889-24-013354
4//SEC Filing

Vig Pamela 4

Accession 0001415889-24-013354

CIK 0001759425other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 4:30 PM ET

Size

5.6 KB

Accession

0001415889-24-013354

Insider Transaction Report

Form 4
Period: 2024-05-10
Vig Pamela
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2024-05-10$21.05/sh+94$1,97827,406 total
Holdings
  • Common Stock

    (indirect: By Trust)
    75,000
Footnotes (1)
  • [F1]This Form 4 is being filed voluntarily to report the acquisition of 94 shares by the Reporting Person on May 10, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.

Issuer

Mirum Pharmaceuticals, Inc.

CIK 0001759425

Entity typeother

Related Parties

1
  • filerCIK 0001780069

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:30 PM ET
Size
5.6 KB